Dragos C. Plesca
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
-
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
- Pharmacy and Medical Practices 2
-
- Hematopoietic Stem Cell Transplantation 2
- Acute Myeloid Leukemia Research 1
- Co-authors
- Alexandru Almasan (7 shared papers)Suparna Mazumder (6 shared papers)Michael T Kinter (1 shared paper)Kathryn Ann A. Culos (1 shared paper)Zahra Mahmoudjafari (1 shared paper)Katie S. Gatwood (1 shared paper)Meredith E. Crosby (1 shared paper)Damodar Gupta (1 shared paper)
- Journals
- Blood (3 papers)Transplantation and Cellular Therapy (2 papers)Cell Cycle (2 papers)Molecular and Cellular Biology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Dragos C. Plesca
16 papers receiving 796 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 65
- Oncology 117
- Molecular Biology 234
- Drug Discovery 1
- Cancer Research 47
Countries citing papers authored by Dragos C. Plesca
This map shows the geographic impact of Dragos C. Plesca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dragos C. Plesca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dragos C. Plesca more than expected).
Fields of papers citing papers by Dragos C. Plesca
This network shows the impact of papers produced by Dragos C. Plesca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dragos C. Plesca. The network helps show where Dragos C. Plesca may publish in the future.
Co-authors
The 25 scholars most cited alongside Dragos C. Plesca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 338 | |
| 2 | 2008 | 183 | |
| 3 | 2018 | 69 | |
| 4 | 2007 | 59 | |
| 5 | 2007 | 32 | |
| 6 | 2019 | 31 | |
| 7 | 2007 | 28 | |
| 8 | 2018 | 23 | |
| 9 | 2008 | 17 | |
| 10 | 2013 | 10 | |
| 11 | 2018 | 5 | |
| 12 | 2020 | 3 | |
| 13 | 2016 | 2 | |
| 14 | 2017 | 2 | |
| 15 | Hematopoietic cell transplantation in chronic myeloid leukemia in the age of tyrosine kinase inhibitors. | 2015 | 1 |
| 16 | 2016 | 1 |
About Dragos C. Plesca
Dragos C. Plesca is a scholar working on Pharmacology, Hematology, Oncology, Molecular Biology and Occupational Therapy, having authored 16 papers that have together received 804 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), DNA Repair Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cancer-related Molecular Pathways (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Pharmacy and Medical Practices (2 papers), Antifungal resistance and susceptibility (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Pharmacology (65 citations), Oncology (117 citations), Molecular Biology (234 citations), Drug Discovery (1 citation) and Cancer Research (47 citations). Dragos C. Plesca has collaborated with scholars based in United States. Frequent co-authors include Alexandru Almasan, Suparna Mazumder, Michael T Kinter, Kathryn Ann A. Culos, Zahra Mahmoudjafari, Katie S. Gatwood, Meredith E. Crosby, Damodar Gupta, Justin R. Arnall and Edward Alan Copelan. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Cell Cycle, Molecular and Cellular Biology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.